The Prosthetic Heart Valve Market is expected to grow at a CAGR of 10.8% during the forecast period (2024-2031). 

The prosthetic heart valve is surgically implanted in the heart to replace a heart valve that has been damaged due to a heart-related disorder. Heart valve replacement surgery is performed when repair of the valve is not an option, each valve has a tissue flap that opens and closes with every heartbeat. 

 

For free sample request: https://www.datamintelligence.com/download-sample/prosthetic-heart-valve-market

Industry Segmentation 

By Product type 

  • Transcatheter Heart Valves 

  • Mechanical Heart Valves 

  • Tissue Heart Valves 

By End User 

  • Hospitals 

  • Ambulatory Surgical Centers 

  • Cardiac Centers 

 

View Full Report: https://www.datamintelligence.com/research-report/prosthetic-heart-valve-market 

 

Industry Key Players 

Key players are Medtronic PLC, Edwards Lifesciences Corporation, Boston Scientific Corporation, Jude Medical Inc. (Abbott Laboratories), Symetis SA, Jenavalve Technology Inc., Cryolife Inc., TTK Healthcare Limited, Colibri Heart Valve LLC and Lepu Medical Technology Co. Ltd.